MedCap AB (publ) (STO:MCAP)

Market Cap	7.70B +35.7%
Revenue (ttm)	1.99B +11.2%
Net Income	196.90M -13.6%
EPS	13.13 -14.2%
Shares Out	15.08M
PE Ratio	38.92
Forward PE	27.92
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,184
Average Volume	18,787
Open	527.00
Previous Close	511.00
Day's Range	490.00 - 527.00
52-Week Range	329.00 - 677.00
Beta	0.52
RSI	43.83
Earnings Date	Feb 6, 2026

About MedCap AB

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, buyout. It prefers to invest in healthcare equipment and services, biotechnology, life sciences, pharmaceuticals, med tech and assistive tech companies. The firm prefers to invest in small to medium size companies that are not listed on the stock exchange and are based in Nordic region and Northern Europe. It typically invests between SEK25 millio...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2001
• Employees: 592
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MCAP

Financial Performance

In 2024, MedCap AB's revenue was 1.81 billion, an increase of 13.74% compared to the previous year's 1.59 billion. Earnings were 207.40 million, an increase of 20.44%.